XML 104 R29.htm IDEA: XBRL DOCUMENT v3.24.4
Stock-based Compensation (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

The Company did not issue any new stock options during the quarter ended September 30, 2024. The following table shows stock option activity for the year ended December 31, 2023 and quarter ended June 30, 2024:

 

                   Weighted 
               Weighted   Average 
   Shares   Outstanding   Average   Remaining   Aggregate 
   Available   Stock   Exercise   Contractual   Intrinsic 
   for Grant   Awards   Price   Life (years)   Value 
Outstanding at December 31,                    
2023   10,455    17,283   $8.20    2.4   $944,544 
Granted   -    -    -    -      
Exercised   -    -    -    -      
Forfeited/cancelled   -    -    -    -      
Outstanding at September 30, 2024   10,455    17,283   $8.20    1.65   $944,544 
Schedule of Restricted Stock Awards Activity

The Company had restricted stock activity summarized as follows:

 

       Weighted 
       Average 
   Number of   Grant 
   Shares   Fair Value 
Outstanding at December 31, 2023   -   $- 
Granted   3,101,277    1.40 
Vested   3,101,277    1.40 
Forfeited/cancelled   -    - 
Restricted shares unvested at March 31, 2024   -    - 
Granted **   2,669,932    1.05 
Vested **   2,669,932    1.05 
Forfeited/cancelled   -    -  
Restricted shares unvested at June 30, 2024   -   $- 
Granted**   

2,654,281

    

0.86

 
Vested**   

2,654,281

    

0.86

 
Restricted shares unvested at September 30, 2024   -    - 

 

Add rows for Q3 and the balance at September 30, 2024

 

**Of the shares granted during the quarters ending June 30, 2024 and September 30, 2024 approximately 1.75 millionn and 2.1 million shares were granted in lieu of making cash payments to satisfy accrued liabilities and approximately 900K shares were issued to compensate for consulting services incurred during the quarter. All shares were registered in the S1 filing and no longer restricted.